|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
FridayDocs Unveil More Findings in Betaseron Trial
The follow-up to a pivotal clinical trial of a currently available multiple sclerosis (MS) therapy is about to wind to a close at nearly a dozen trial sites around the country. It's the longest follow-up of a clinical trial involving Betaseron (interferon beta-1b), spanning nearly two decades. The latest results from the follow-up trial were released in late September at a meeting of neurologists in San DiegMS Neighborhood : MORE
|